UNRESOLVED INFLAMMATION: 'IMMUNE TSUNAMI' AND CANCER CACHEXIA INDUCED BY "TARGETED" THERAPIES

被引：0
|
作者：
Khatami, Mahin [1 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
来源：
INFLAMMATION RESEARCH | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [41] Microbiota-targeted therapies in inflammation resolution
    Strati, Francesco
    Lattanzi, Georgia
    Amoroso, Chiara
    Facciotti, Federica
    SEMINARS IN IMMUNOLOGY, 2022, 59
  • [42] The FAP plus stromal cell: Cancer-induced immune suppression and cachexia
    Fearon, Douglas T.
    CANCER RESEARCH, 2012, 72
  • [43] Targeted Radiation and Immune Therapies-Advances and Opportunities for the Treatment of Prostate Cancer
    Muralidhar, Anusha
    Potluri, Hemanth K.
    Jaiswal, Tanya
    McNeel, Douglas G.
    PHARMACEUTICS, 2023, 15 (01)
  • [44] Cancer cachexia and chronic inflammation: an unbreakable bond
    Maccio, Antonio
    Madeddu, Clelia
    Lai, Eleonora
    Scartozzi, Mario
    BRITISH JOURNAL OF CANCER, 2023, 128 (09) : 1609 - 1610
  • [45] Mitochondrial dysfunction caused inflammation and cancer cachexia
    Mori, Shiori
    Kishi, Shingo
    Mori, Takuya
    Nukaga, Shota
    Tani, Rina
    Nishida, Ryoichi
    Kawahara, Isao
    Kuniyasu, Hiroki
    CANCER SCIENCE, 2023, 114 : 2118 - 2118
  • [46] Inflammation in cancer cachexia: To resolve or not to resolve (is that the question?)
    Seelaender, Marilia
    Batista Junior, Miguel
    Lira, Fabio
    Silverio, Renata
    Rossi-Fanelli, Filippo
    CLINICAL NUTRITION, 2012, 31 (04) : 562 - 566
  • [47] Systemic inflammation, cachexia and prognosis in patients with cancer
    Deans, C
    Wigmore, SJ
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (03): : 265 - 269
  • [48] Cancer cachexia and chronic inflammation: an unbreakable bond
    Antonio Macciò
    Clelia Madeddu
    Eleonora Lai
    Mario Scartozzi
    British Journal of Cancer, 2023, 128 : 1609 - 1610
  • [49] Targeted Therapies for Pancreatic Cancer
    Ma, Qingyong
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (17) : 2393 - 2394
  • [50] Targeted therapies in lung cancer
    Besse, B.
    Ropert, S.
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2007, 18 : 135 - 142
12345